Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current clinical practices for ovarian cancers.

Peter Harper1

  • 1Medical Oncology Department, Guy's Hospital, London, UK.

Seminars in Oncology
|June 26, 2002
PubMed
Summary

Effective ovarian cancer chemotherapy combines paclitaxel with either cisplatin or carboplatin. Carboplatin offers similar efficacy with better toxicity, guiding current treatment strategies for this aggressive gynecologic cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Multimodal Quality Improvement Approach to Reduce Sevoflurane Consumption and Greenhouse Gas Emissions in an Academic Health System.

Cureus·2026
Same author

Exploring Rurality and Racial/Ethnic Disparities in Texas Mortality: A Scoping Review of the Five Leading Causes of Death.

Journal of racial and ethnic health disparities·2025
Same author

Psychological Adaptation in a Mixed Sex and Ability Team During a Ski Expedition to the South Pole.

Aerospace medicine and human performance·2025
Same author

Overcoming challenges of prescribing long-term opioid therapy in residency clinics.

Journal of opioid management·2024
Same author

The experience of UK patients with bladder cancer during the second wave of the COVID-19 pandemic.

BJUI compass·2022
Same author

The experience of UK patients with bladder cancer during the COVID-19 pandemic: a survey-based snapshot.

BJU international·2020

Area of Science:

  • Gynecologic Oncology
  • Medical Chemistry
  • Clinical Pharmacology

Background:

  • Ovarian cancer is a highly aggressive gynecologic malignancy.
  • Late symptom presentation frequently leads to advanced-stage diagnosis.
  • There is a critical need for improved chemotherapy regimens.

Purpose of the Study:

  • To review studies on paclitaxel-based chemotherapy for ovarian cancer.
  • To summarize current trends in ovarian cancer treatment.
  • To compare the efficacy and toxicity of different chemotherapy combinations.

Main Methods:

  • Review of representative clinical studies evaluating paclitaxel combination therapies.
  • Analysis of historical and contemporary treatment regimens.
  • Comparison of survival data and toxicity profiles.

Main Results:

  • Cisplatin and paclitaxel combination therapy prolongs survival compared to older regimens (cisplatin/cyclophosphamide).
  • Carboplatin and paclitaxel combination shows comparable efficacy to cisplatin/paclitaxel.
  • Carboplatin/paclitaxel offers a preferable toxicity profile over cisplatin/paclitaxel.

Conclusions:

  • Paclitaxel-based chemotherapy, particularly with carboplatin, represents a significant advancement in ovarian cancer treatment.
  • The choice between cisplatin and carboplatin in combination therapy should consider both efficacy and patient tolerability.
  • Ongoing research and evolving treatment strategies are crucial for managing advanced-stage ovarian cancer.

Related Experiment Videos